Smartlab Europe

Press Releases

Successful First-in-Human Testing of Implandata’s Next Generation EYEMATE™ Micro-Sensor for Improved Monitoring of Glaucoma Patients

Implandata Ophthalmic Products GmbH (Implandata) is a privately held, ISO 13485 certified medical device company founded in 2010 in Hannover/Germany. Implandata’s EYEMATE™ system for continuous monitoring of intraocular pressure (IOP) and improved disease care at glaucoma...

Swisslog follows global customers with two major contract wins in Japanese medical devices industry

Swisslog, a global provider of robot and data-driven intralogistics solutions, has been awarded contracts to optimize the storage and handling of medical devices from two world-leading brands in Japan. Both systems include the automated small parts...

IMAEH Hospital joins Clinerion’s PRS network of hospitals

The Mehmet Akif Ersoy Göğüs Kalp Damar Cerrahisi Eğitim Araştırma Hastanesi (IMAEH) hospital in Istanbul has joined the network of hospitals on Clinerion’s PRS platform. The Istanbul Mehmet Akif Ersoy Hospital provides care for all medical...

Pharma set for prosperous 2018 as 44,500* attend CPhI Worldwide

CPhI Worldwide, organised by UBM, closes its 28th edition with pre-audit figures indicating a record-breaking attendance of over 44,500* and 2,598 exhibitors. Held in Frankfurt (Germany), the heart of Europe’s biggest pharmaceutical market (24-26th October, 2017), the world’s largest...

Immuno-oncology CRO secures Macrophage Pharma agreement

Aquila BioMedical Ltd., an innovative preclinical contract research organisation (CRO) now part of Concept Life Sciences group, has secured an extended agreement with UK-based biotech firm Macrophage Pharma Ltd. to support its preclinical immuno-oncology programmes. Macrophage...

Omya presented multifunctional minerals at CPhI

Following its CPhI Europe banner headline “Enlighten your formulation”, Omya has shown how its calcium carbonates can be used to develop tailor-made products in response to specific consumer or patient needs in a variety of pharmaceutical forms. ...

CluePoints Builds on Late Phase work in Japan and Launches Risk-Based Monitoring Roadshow in Tokyo

CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has further expanded its Late Phase work in Japan by entering into two new partnerships with global top 20 pharmaceutical companies. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »